Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Dam

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Plos One|September 11, 2010
Array-based DNA methylation profiling for breast cancer subtype discriminationIlse Van der Auwera, Wayne Yu, Liping Suo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancerSteven Van Laere, Tim Beissbarth, Ilse Van der Auwera, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 14, 2025
Locally advanced breast cancers: the EUSOMA experiencePeter van Dam, Mariano Tomatis, Antonio Ponti, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centresPeter van Dam, Mariano Tomatis, Antonio Ponti, et al.
Cancers|March 6, 2021
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic CancerAndreas Domen, Delphine Quatannens, Sara Zanivan, et al.
Breast Cancer Research and Treatment|November 2, 2005
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profilingSteven J Van Laere, Gert G Van den Eynden, Ilse Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2026
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA databaseCynthia Aristei, Mariano Tomatis, Antonio Ponti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based studyIsabelle Savoye, Geert Silversmit, Jolyce Bourgeois, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 2, 2024
Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patientsJolyce Bourgeois, Hanna M Peacock, Isabelle Savoye, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Plos One|September 11, 2010
Array-based DNA methylation profiling for breast cancer subtype discriminationIlse Van der Auwera, Wayne Yu, Liping Suo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancerSteven Van Laere, Tim Beissbarth, Ilse Van der Auwera, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 14, 2025
Locally advanced breast cancers: the EUSOMA experiencePeter van Dam, Mariano Tomatis, Antonio Ponti, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centresPeter van Dam, Mariano Tomatis, Antonio Ponti, et al.
Cancers|March 6, 2021
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic CancerAndreas Domen, Delphine Quatannens, Sara Zanivan, et al.
Breast Cancer Research and Treatment|November 2, 2005
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profilingSteven J Van Laere, Gert G Van den Eynden, Ilse Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2026
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA databaseCynthia Aristei, Mariano Tomatis, Antonio Ponti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based studyIsabelle Savoye, Geert Silversmit, Jolyce Bourgeois, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 2, 2024
Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patientsJolyce Bourgeois, Hanna M Peacock, Isabelle Savoye, et al.
Pageof 12